These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8492477)

  • 21. Calprotectin and lactoferrin in the assessment of intestinal inflammation and organic disease.
    D'Incà R; Dal Pont E; Di Leo V; Ferronato A; Fries W; Vettorato MG; Martines D; Sturniolo GC
    Int J Colorectal Dis; 2007 Apr; 22(4):429-37. PubMed ID: 16838143
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biliary lactoferrin concentrations are increased in active inflammatory bowel disease: a factor in the pathogenesis of primary sclerosing cholangitis?
    Pereira SP; Rhodes JM; Campbell BJ; Kumar D; Bain IM; Murphy GM; Dowling RH
    Clin Sci (Lond); 1998 Nov; 95(5):637-44. PubMed ID: 9791051
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fecal lactoferrin is a sensitive and specific marker of disease activity in children and young adults with inflammatory bowel disease.
    Walker TR; Land ML; Kartashov A; Saslowsky TM; Lyerly DM; Boone JH; Rufo PA
    J Pediatr Gastroenterol Nutr; 2007 Apr; 44(4):414-22. PubMed ID: 17414136
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential excretion of leucocyte granule components in inflammatory bowel disease: implications for pathogenesis.
    Dwarakanath AD; Finnie IA; Beesley CM; O'Dowd GM; Nash J; Tsai HH; Parker N; Rhodes JM
    Clin Sci (Lond); 1997 Mar; 92(3):307-13. PubMed ID: 9093012
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between fecal lactoferrin and inflammatory bowel disease.
    Dai J; Liu WZ; Zhao YP; Hu YB; Ge ZZ
    Scand J Gastroenterol; 2007 Dec; 42(12):1440-4. PubMed ID: 17852860
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Usefulness of fecal lactoferrin and hemoglobin in diagnosis of colorectal diseases.
    Hirata I; Hoshimoto M; Saito O; Kayazawa M; Nishikawa T; Murano M; Toshina K; Wang FY; Matsuse R
    World J Gastroenterol; 2007 Mar; 13(10):1569-74. PubMed ID: 17461450
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic accuracy of fecal lactoferrin for inflammatory bowel disease: a meta-analysis.
    Wang Y; Pei F; Wang X; Sun Z; Hu C; Dou H
    Int J Clin Exp Pathol; 2015; 8(10):12319-32. PubMed ID: 26722419
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical utility of fecal biomarkers for the diagnosis and management of inflammatory bowel disease.
    Kopylov U; Rosenfeld G; Bressler B; Seidman E
    Inflamm Bowel Dis; 2014 Apr; 20(4):742-56. PubMed ID: 24562174
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Exocrine function of the pancreas in patients with ulcerative colitis].
    Burkovskaia VA; Beloborodova EI; Glinskaia ON; Markidonova AA; Naumova EL; Akimova LA; Kvach EA; Kaksht AE
    Klin Med (Mosk); 2010; 88(1):46-9. PubMed ID: 20369612
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fecal eosinophil granule-derived proteins reflect disease activity in inflammatory bowel disease.
    Saitoh O; Kojima K; Sugi K; Matsuse R; Uchida K; Tabata K; Nakagawa K; Kayazawa M; Hirata I; Katsu K
    Am J Gastroenterol; 1999 Dec; 94(12):3513-20. PubMed ID: 10606313
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fecal HMGB1 Reveals Microscopic Inflammation in Adult and Pediatric Patients with Inflammatory Bowel Disease in Clinical and Endoscopic Remission.
    Palone F; Vitali R; Cucchiara S; Mennini M; Armuzzi A; Pugliese D; DʼIncà R; Barberio B; Stronati L
    Inflamm Bowel Dis; 2016 Dec; 22(12):2886-2893. PubMed ID: 27755215
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fecal osteoprotegerin may guide the introduction of second-line therapy in hospitalized children with ulcerative colitis.
    Sylvester FA; Turner D; Draghi A; Uuosoe K; McLernon R; Koproske K; Mack DR; Crandall WV; Hyams JS; Leleiko NS; Griffiths AM
    Inflamm Bowel Dis; 2011 Aug; 17(8):1726-30. PubMed ID: 21744427
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fecal lactoferrin assay as a cost-effective tool for intestinal inflammation.
    Vaishnavi C; Bhasin DK; Singh K
    Am J Gastroenterol; 2000 Oct; 95(10):3002-3. PubMed ID: 11051400
    [No Abstract]   [Full Text] [Related]  

  • 34. Neutrophils in ulcerative colitis: a review of selected biomarkers and their potential therapeutic implications.
    Muthas D; Reznichenko A; Balendran CA; Böttcher G; Clausen IG; Kärrman Mårdh C; Ottosson T; Uddin M; MacDonald TT; Danese S; Berner Hansen M
    Scand J Gastroenterol; 2017 Feb; 52(2):125-135. PubMed ID: 27610713
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Faecal Lactoferrin, Calprotectin, PMN-elastase, CRP, and White Blood Cell Count as Indicators for Mucosal Healing and Clinical Course of Disease in Patients with Mild to Moderate Ulcerative Colitis: Post Hoc Analysis of a Prospective Clinical Trial.
    Langhorst J; Boone J; Lauche R; Rueffer A; Dobos G
    J Crohns Colitis; 2016 Jul; 10(7):786-94. PubMed ID: 26874351
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of feces from patients with ulcerative colitis on butyrate oxidation in rat colonocytes.
    Jørgensen JR; Mortensen PB
    Dig Dis Sci; 1999 Oct; 44(10):2099-109. PubMed ID: 10548364
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A prospective study of fecal calprotectin and lactoferrin as predictors of small bowel Crohn's disease in patients undergoing capsule endoscopy.
    Bar-Gil Shitrit A; Koslowsky B; Livovsky DM; Shitrit D; Paz K; Adar T; Adler SN; Goldin E
    Scand J Gastroenterol; 2017 Mar; 52(3):328-333. PubMed ID: 27841040
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Histological Outcomes and Predictive Value of Faecal Markers in Moderately to Severely Active Ulcerative Colitis Patients Receiving Infliximab.
    Magro F; Lopes SI; Lopes J; Portela F; Cotter J; Lopes S; Moreira MJ; Lago P; Peixe P; Albuquerque A; Rodrigues S; Silva MR; Monteiro P; Lopes C; Monteiro L; Macedo G; Veloso L; Camila C; Afonso J; Geboes K; Carneiro F;
    J Crohns Colitis; 2016 Dec; 10(12):1407-1416. PubMed ID: 27226417
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The value of fecal calprotectin as a marker of intestinal inflammation in patients with ulcerative colitis.
    Önal İK; Beyazit Y; Şener B; Savuk B; Özer Etık D; Sayilir A; Öztaş E; Torun S; Özderın Özın Y; Tunç Demırel B; Ülker A; Dağli Ü
    Turk J Gastroenterol; 2012; 23(5):509-14. PubMed ID: 23161295
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elevated human beta-defensin-2 levels indicate an activation of the innate immune system in patients with irritable bowel syndrome.
    Langhorst J; Junge A; Rueffer A; Wehkamp J; Foell D; Michalsen A; Musial F; Dobos GJ
    Am J Gastroenterol; 2009 Feb; 104(2):404-10. PubMed ID: 19174795
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.